Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innovex International (INVX) Research & Development (2016 - 2024)

Innovex International (INVX) has disclosed Research & Development for 16 consecutive years, with $3.6 million as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Research & Development rose 12.05% year-over-year to $3.6 million, compared with a TTM value of $13.4 million through Jun 2024, up 11.96%, and an annual FY2023 reading of $12.6 million, up 7.74% over the prior year.
  • Research & Development was $3.6 million for Q2 2024 at Innovex International, down from $3.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $5.5 million in Q1 2020 and bottomed at $2.6 million in Q3 2022.
  • Average Research & Development over 5 years is $3.7 million, with a median of $3.6 million recorded in 2022.
  • The sharpest move saw Research & Development skyrocketed 131.54% in 2020, then tumbled 30.61% in 2021.
  • Year by year, Research & Development stood at $4.0 million in 2020, then fell by 5.05% to $3.8 million in 2021, then fell by 29.6% to $2.7 million in 2022, then grew by 10.67% to $3.0 million in 2023, then grew by 20.12% to $3.6 million in 2024.
  • Business Quant data shows Research & Development for INVX at $3.6 million in Q2 2024, $3.7 million in Q1 2024, and $3.0 million in Q4 2023.